Giulia Borella
Overview
Explore the profile of Giulia Borella including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
61
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tregnago C, Benetton M, Da Ros A, Borella G, Longo G, Polato K, et al.
Front Pharmacol
. 2022 Feb;
12:820191.
PMID: 35153769
In pediatric acute myeloid leukemia (AML), fusions involving lysine methyltransferase 2A (KMT2A) are considered hallmarks of aggressive AML, for whom the development of targeted specific therapeutic agents to ameliorate classic...
2.
Porcu E, Benetton M, Bisio V, Da Ros A, Tregnago C, Borella G, et al.
iScience
. 2021 Nov;
24(11):103350.
PMID: 34816103
Patients with acute myeloid leukemia (AML) carrying high-risk genetic lesions or high residual disease levels after therapy are particularly exposed to the risk of relapse. Here, we identified the long...
3.
Tregnago C, Benetton M, Padrin D, Polato K, Borella G, Da Ros A, et al.
Cancers (Basel)
. 2021 Jul;
13(14).
PMID: 34298672
Nucleophosmin (NPM1) is a nucleocytoplasmic shuttling protein, predominantly located in the nucleolus, that regulates a multiplicity of different biological processes. NPM1 localization in the cell is finely tuned by specific...
4.
Borella G, Da Ros A, Borile G, Porcu E, Tregnago C, Benetton M, et al.
Blood
. 2021 May;
138(7):557-570.
PMID: 34010415
Bone marrow (BM) microenvironment contributes to the regulation of normal hematopoiesis through a finely tuned balance of self-renewal and differentiation processes, cell-cell interaction, and secretion of cytokines that during leukemogenesis...
5.
Tregnago C, Da Ros A, Porcu E, Benetton M, Simonato M, Simula L, et al.
Blood Adv
. 2020 Sep;
4(18):4417-4429.
PMID: 32931582
In pediatric acute myeloid leukemia (AML), intensive chemotherapy and allogeneic hematopoietic stem cell transplantation are the cornerstones of treatment in high-risk cases, with severe late effects and a still high...
6.
Zampini M, Tregnago C, Bisio V, Simula L, Borella G, Manara E, et al.
Leukemia
. 2018 Feb;
32(5):1124-1134.
PMID: 29472719
The somatic translocation t(8;21)(q22;q22)/RUNX1-RUNX1T1 is one of the most frequent rearrangements found in children with standard-risk acute myeloid leukemia (AML). Despite the favorable prognostic role of this aberration, we recently...